Evaluating other clinicopathological data, we can assert that aggressive disease is driven by classical clinicopathological features of aggressiveness: in multivariate analysis, extrathyroidal infiltration and TERT promoter mutational status show the strongest association for RFS and DRFS, while a larger tumor size plays an important role even if only in association with RFS. The gene discussed is TERT; the disease is neoplasm.